A	O
Novel	O
Selective	O
Inhibitor	B:C0014432
of	O
Delta	O
-	I:C0057338
5	I:C0057338
Desaturase	I:C0057338
Lowers	O
Insulin	O
Resistance	I:C0021655
and	O
Reduces	O
Body	I:C1262477
Weight	I:C1262477
in	O
Diet	O
-	O
Induced	O
Obese	O
C57BL	O
/6J	I:C1521751

A	O
Novel	O
Selective	O
Inhibitor	O
of	O
Delta	B:C0057338
-	I:C0057338
5	I:C0057338
Desaturase	I:C0057338
Lowers	O
Insulin	O
Resistance	I:C0021655
and	O
Reduces	O
Body	I:C1262477
Weight	I:C1262477
in	O
Diet	O
-	O
Induced	O
Obese	O
C57BL	O
/6J	I:C1521751

A	O
Novel	O
Selective	O
Inhibitor	O
of	O
Delta	O
-	I:C0057338
5	I:C0057338
Desaturase	I:C0057338
Lowers	O
Insulin	B:C0021655
Resistance	I:C0021655
and	O
Reduces	O
Body	I:C1262477
Weight	I:C1262477
in	O
Diet	O
-	O
Induced	O
Obese	O
C57BL	O
/6J	I:C1521751

A	O
Novel	O
Selective	O
Inhibitor	O
of	O
Delta	O
-	I:C0057338
5	I:C0057338
Desaturase	I:C0057338
Lowers	O
Insulin	O
Resistance	I:C0021655
and	O
Reduces	B:C1262477
Body	I:C1262477
Weight	I:C1262477
in	O
Diet	O
-	O
Induced	O
Obese	O
C57BL	O
/6J	I:C1521751

A	O
Novel	O
Selective	O
Inhibitor	O
of	O
Delta	O
-	I:C0057338
5	I:C0057338
Desaturase	I:C0057338
Lowers	O
Insulin	O
Resistance	I:C0021655
and	O
Reduces	O
Body	I:C1262477
Weight	I:C1262477
in	O
Diet	B:C0012155
-	O
Induced	O
Obese	O
C57BL	O
/6J	I:C1521751

A	O
Novel	O
Selective	O
Inhibitor	O
of	O
Delta	O
-	I:C0057338
5	I:C0057338
Desaturase	I:C0057338
Lowers	O
Insulin	O
Resistance	I:C0021655
and	O
Reduces	O
Body	I:C1262477
Weight	I:C1262477
in	O
Diet	O
-	O
Induced	O
Obese	B:C0028754
C57BL	O
/6J	I:C1521751

A	O
Novel	O
Selective	O
Inhibitor	O
of	O
Delta	O
-	I:C0057338
5	I:C0057338
Desaturase	I:C0057338
Lowers	O
Insulin	O
Resistance	I:C0021655
and	O
Reduces	O
Body	I:C1262477
Weight	I:C1262477
in	O
Diet	O
-	O
Induced	O
Obese	O
C57BL	B:C1521751
/6J	I:C1521751

Obesity	B:C0028754
is	O
now	O
recognized	O
as	O
a	O
state	O
of	O
chronic	O
low	O
-	O
grade	O
inflammation	O
and	O
is	O
called	O
as	O
metabolic	O
inflammation	O
.	O

Obesity	O
is	O
now	O
recognized	O
as	O
a	O
state	O
of	O
chronic	O
low	O
-	O
grade	O
inflammation	B:C0021368
and	O
is	O
called	O
as	O
metabolic	O
inflammation	O
.	O

Obesity	O
is	O
now	O
recognized	O
as	O
a	O
state	O
of	O
chronic	O
low	O
-	O
grade	O
inflammation	O
and	O
is	O
called	O
as	O
metabolic	O
inflammation	B:C0021368
.	O

Delta	B:C0057338
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
(	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
)	O
is	O
an	O
enzyme	O
that	O
metabolizes	O
dihomo	O
-	I:C0000658
γ-	I:C0000658
linolenic	I:C0000658
acid	I:C0000658
(	O
DGLA	O
)	O
to	O
arachidonic	O
acid	I:C0003695
(	O
arachidonic	O
acid	I:C0003695
)	O
.	O

Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
(	O
Delta	B:C0057338
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
)	O
is	O
an	O
enzyme	O
that	O
metabolizes	O
dihomo	O
-	I:C0000658
γ-	I:C0000658
linolenic	I:C0000658
acid	I:C0000658
(	O
DGLA	O
)	O
to	O
arachidonic	O
acid	I:C0003695
(	O
arachidonic	O
acid	I:C0003695
)	O
.	O

Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
(	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
)	O
is	O
an	O
enzyme	B:C0014442
that	O
metabolizes	O
dihomo	O
-	I:C0000658
γ-	I:C0000658
linolenic	I:C0000658
acid	I:C0000658
(	O
DGLA	O
)	O
to	O
arachidonic	O
acid	I:C0003695
(	O
arachidonic	O
acid	I:C0003695
)	O
.	O

Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
(	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
)	O
is	O
an	O
enzyme	O
that	O
metabolizes	O
dihomo	B:C0000658
-	I:C0000658
γ-	I:C0000658
linolenic	I:C0000658
acid	I:C0000658
(	O
DGLA	O
)	O
to	O
arachidonic	O
acid	I:C0003695
(	O
arachidonic	O
acid	I:C0003695
)	O
.	O

Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
(	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
)	O
is	O
an	O
enzyme	O
that	O
metabolizes	O
dihomo	O
-	I:C0000658
γ-	I:C0000658
linolenic	I:C0000658
acid	I:C0000658
(	O
DGLA	B:C0000658
)	O
to	O
arachidonic	O
acid	I:C0003695
(	O
arachidonic	O
acid	I:C0003695
)	O
.	O

Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
(	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
)	O
is	O
an	O
enzyme	O
that	O
metabolizes	O
dihomo	O
-	I:C0000658
γ-	I:C0000658
linolenic	I:C0000658
acid	I:C0000658
(	O
DGLA	O
)	O
to	O
arachidonic	B:C0003695
acid	I:C0003695
(	O
arachidonic	O
acid	I:C0003695
)	O
.	O

Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
(	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
)	O
is	O
an	O
enzyme	O
that	O
metabolizes	O
dihomo	O
-	I:C0000658
γ-	I:C0000658
linolenic	I:C0000658
acid	I:C0000658
(	O
DGLA	O
)	O
to	O
arachidonic	O
acid	I:C0003695
(	O
arachidonic	B:C0003695
acid	I:C0003695
)	O
.	O

Thus	O
,	O
Delta	B:C0057338
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
inhibition	O
increases	O
DGLA	O
(	O
precursor	O
to	O
anti-inflammatory	O
eicosanoids	O
)	O
while	O
decreasing	O
arachidonic	O
acid	I:C0003695
(	O
precursor	O
to	O
pro-inflammatory	O
eicosanoids	O
)	O
,	O
and	O
could	O
result	O
in	O
synergistic	O
improvement	O
in	O
the	O
low	O
-	O
grade	O
inflammatory	O
state	O
.	O

Thus	O
,	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
inhibition	B:C1524081
increases	O
DGLA	O
(	O
precursor	O
to	O
anti-inflammatory	O
eicosanoids	O
)	O
while	O
decreasing	O
arachidonic	O
acid	I:C0003695
(	O
precursor	O
to	O
pro-inflammatory	O
eicosanoids	O
)	O
,	O
and	O
could	O
result	O
in	O
synergistic	O
improvement	O
in	O
the	O
low	O
-	O
grade	O
inflammatory	O
state	O
.	O

Thus	O
,	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
inhibition	O
increases	O
DGLA	B:C0000658
(	O
precursor	O
to	O
anti-inflammatory	O
eicosanoids	O
)	O
while	O
decreasing	O
arachidonic	O
acid	I:C0003695
(	O
precursor	O
to	O
pro-inflammatory	O
eicosanoids	O
)	O
,	O
and	O
could	O
result	O
in	O
synergistic	O
improvement	O
in	O
the	O
low	O
-	O
grade	O
inflammatory	O
state	O
.	O

Thus	O
,	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
inhibition	O
increases	O
DGLA	O
(	O
precursor	O
to	O
anti-inflammatory	O
eicosanoids	B:C0013725
)	O
while	O
decreasing	O
arachidonic	O
acid	I:C0003695
(	O
precursor	O
to	O
pro-inflammatory	O
eicosanoids	O
)	O
,	O
and	O
could	O
result	O
in	O
synergistic	O
improvement	O
in	O
the	O
low	O
-	O
grade	O
inflammatory	O
state	O
.	O

Thus	O
,	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
inhibition	O
increases	O
DGLA	O
(	O
precursor	O
to	O
anti-inflammatory	O
eicosanoids	O
)	O
while	O
decreasing	O
arachidonic	B:C0003695
acid	I:C0003695
(	O
precursor	O
to	O
pro-inflammatory	O
eicosanoids	O
)	O
,	O
and	O
could	O
result	O
in	O
synergistic	O
improvement	O
in	O
the	O
low	O
-	O
grade	O
inflammatory	O
state	O
.	O

Thus	O
,	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
inhibition	O
increases	O
DGLA	O
(	O
precursor	O
to	O
anti-inflammatory	O
eicosanoids	O
)	O
while	O
decreasing	O
arachidonic	O
acid	I:C0003695
(	O
precursor	O
to	O
pro-inflammatory	O
eicosanoids	B:C0013725
)	O
,	O
and	O
could	O
result	O
in	O
synergistic	O
improvement	O
in	O
the	O
low	O
-	O
grade	O
inflammatory	O
state	O
.	O

Here	O
,	O
we	O
demonstrate	O
reduced	O
insulin	B:C0021655
resistance	I:C0021655
and	O
the	O
anti-obesity	O
effect	O
of	O
a	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
selective	O
inhibitor	O
(	O
compound	O
-	I:C1254351
326	I:C1254351
)	O
,	O
an	O
orally	O
active	O
small	O
-	I:C1328819
molecule	I:C1328819
,	O
in	O
a	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
induced	O
obese	O
(	I:C0025933
DIO	I:C0025933
)	I:C0025933
mouse	I:C0025933
model	O
.	O

Here	O
,	O
we	O
demonstrate	O
reduced	O
insulin	O
resistance	I:C0021655
and	O
the	O
anti-obesity	B:C0376607
effect	O
of	O
a	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
selective	O
inhibitor	O
(	O
compound	O
-	I:C1254351
326	I:C1254351
)	O
,	O
an	O
orally	O
active	O
small	O
-	I:C1328819
molecule	I:C1328819
,	O
in	O
a	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
induced	O
obese	O
(	I:C0025933
DIO	I:C0025933
)	I:C0025933
mouse	I:C0025933
model	O
.	O

Here	O
,	O
we	O
demonstrate	O
reduced	O
insulin	O
resistance	I:C0021655
and	O
the	O
anti-obesity	O
effect	O
of	O
a	O
Delta	B:C0057338
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
selective	O
inhibitor	O
(	O
compound	O
-	I:C1254351
326	I:C1254351
)	O
,	O
an	O
orally	O
active	O
small	O
-	I:C1328819
molecule	I:C1328819
,	O
in	O
a	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
induced	O
obese	O
(	I:C0025933
DIO	I:C0025933
)	I:C0025933
mouse	I:C0025933
model	O
.	O

Here	O
,	O
we	O
demonstrate	O
reduced	O
insulin	O
resistance	I:C0021655
and	O
the	O
anti-obesity	O
effect	O
of	O
a	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
selective	O
inhibitor	O
(	O
compound	B:C1254351
-	I:C1254351
326	I:C1254351
)	O
,	O
an	O
orally	O
active	O
small	O
-	I:C1328819
molecule	I:C1328819
,	O
in	O
a	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
induced	O
obese	O
(	I:C0025933
DIO	I:C0025933
)	I:C0025933
mouse	I:C0025933
model	O
.	O

Here	O
,	O
we	O
demonstrate	O
reduced	O
insulin	O
resistance	I:C0021655
and	O
the	O
anti-obesity	O
effect	O
of	O
a	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
selective	O
inhibitor	O
(	O
compound	O
-	I:C1254351
326	I:C1254351
)	O
,	O
an	O
orally	B:C0442027
active	O
small	O
-	I:C1328819
molecule	I:C1328819
,	O
in	O
a	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
induced	O
obese	O
(	I:C0025933
DIO	I:C0025933
)	I:C0025933
mouse	I:C0025933
model	O
.	O

Here	O
,	O
we	O
demonstrate	O
reduced	O
insulin	O
resistance	I:C0021655
and	O
the	O
anti-obesity	O
effect	O
of	O
a	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
selective	O
inhibitor	O
(	O
compound	O
-	I:C1254351
326	I:C1254351
)	O
,	O
an	O
orally	O
active	O
small	B:C1328819
-	I:C1328819
molecule	I:C1328819
,	O
in	O
a	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
induced	O
obese	O
(	I:C0025933
DIO	I:C0025933
)	I:C0025933
mouse	I:C0025933
model	O
.	O

Here	O
,	O
we	O
demonstrate	O
reduced	O
insulin	O
resistance	I:C0021655
and	O
the	O
anti-obesity	O
effect	O
of	O
a	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
selective	O
inhibitor	O
(	O
compound	O
-	I:C1254351
326	I:C1254351
)	O
,	O
an	O
orally	O
active	O
small	O
-	I:C1328819
molecule	I:C1328819
,	O
in	O
a	O
high	B:C0453819
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
induced	O
obese	O
(	I:C0025933
DIO	I:C0025933
)	I:C0025933
mouse	I:C0025933
model	O
.	O

Here	O
,	O
we	O
demonstrate	O
reduced	O
insulin	O
resistance	I:C0021655
and	O
the	O
anti-obesity	O
effect	O
of	O
a	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
selective	O
inhibitor	O
(	O
compound	O
-	I:C1254351
326	I:C1254351
)	O
,	O
an	O
orally	O
active	O
small	O
-	I:C1328819
molecule	I:C1328819
,	O
in	O
a	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
induced	O
obese	B:C0025933
(	I:C0025933
DIO	I:C0025933
)	I:C0025933
mouse	I:C0025933
model	O
.	O

Here	O
,	O
we	O
demonstrate	O
reduced	O
insulin	O
resistance	I:C0021655
and	O
the	O
anti-obesity	O
effect	O
of	O
a	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
selective	O
inhibitor	O
(	O
compound	O
-	I:C1254351
326	I:C1254351
)	O
,	O
an	O
orally	O
active	O
small	O
-	I:C1328819
molecule	I:C1328819
,	O
in	O
a	O
high	O
-	I:C0453819
fat	I:C0453819
diet	I:C0453819
-	O
induced	O
obese	O
(	I:C0025933
DIO	I:C0025933
)	I:C0025933
mouse	I:C0025933
model	B:C0012644
.	O

In	O
vivo	O
Delta	B:C0057338
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
inhibition	O
was	O
confirmed	O
by	O
determining	O
changes	O
in	O
blood	O
arachidonic	O
acid	I:C0003695
/	O
DGLA	O
profiles	O
.	O

In	O
vivo	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
inhibition	B:C1524081
was	O
confirmed	O
by	O
determining	O
changes	O
in	O
blood	O
arachidonic	O
acid	I:C0003695
/	O
DGLA	O
profiles	O
.	O

In	O
vivo	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
inhibition	O
was	O
confirmed	O
by	O
determining	O
changes	O
in	O
blood	B:C0005767
arachidonic	O
acid	I:C0003695
/	O
DGLA	O
profiles	O
.	O

In	O
vivo	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
inhibition	O
was	O
confirmed	O
by	O
determining	O
changes	O
in	O
blood	O
arachidonic	B:C0003695
acid	I:C0003695
/	O
DGLA	O
profiles	O
.	O

In	O
vivo	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
inhibition	O
was	O
confirmed	O
by	O
determining	O
changes	O
in	O
blood	O
arachidonic	O
acid	I:C0003695
/	O
DGLA	B:C0000658
profiles	O
.	O

In	O
DIO	B:C0025933
mice	I:C0025933
,	O
chronic	O
treatment	O
with	O
compound	O
-	I:C1254351
326	I:C1254351
lowered	O
insulin	O
resistance	I:C0021655
and	O
caused	O
body	O
weight	I:C1262477
loss	I:C1262477
without	O
significant	O
impact	O
on	O
cumulative	O
calorie	O
intake	O
.	O

In	O
DIO	O
mice	I:C0025933
,	O
chronic	O
treatment	O
with	O
compound	B:C1254351
-	I:C1254351
326	I:C1254351
lowered	O
insulin	O
resistance	I:C0021655
and	O
caused	O
body	O
weight	I:C1262477
loss	I:C1262477
without	O
significant	O
impact	O
on	O
cumulative	O
calorie	O
intake	O
.	O

In	O
DIO	O
mice	I:C0025933
,	O
chronic	O
treatment	O
with	O
compound	O
-	I:C1254351
326	I:C1254351
lowered	O
insulin	B:C0021655
resistance	I:C0021655
and	O
caused	O
body	O
weight	I:C1262477
loss	I:C1262477
without	O
significant	O
impact	O
on	O
cumulative	O
calorie	O
intake	O
.	O

In	O
DIO	O
mice	I:C0025933
,	O
chronic	O
treatment	O
with	O
compound	O
-	I:C1254351
326	I:C1254351
lowered	O
insulin	O
resistance	I:C0021655
and	O
caused	O
body	B:C1262477
weight	I:C1262477
loss	I:C1262477
without	O
significant	O
impact	O
on	O
cumulative	O
calorie	O
intake	O
.	O

Decreased	O
macrophage	B:C4014887
infiltration	I:C4014887
into	I:C4014887
adipose	I:C4014887
tissue	I:C4014887
was	O
expected	O
from	O
mRNA	O
analysis	I:C0872262
.	O

Decreased	O
macrophage	O
infiltration	I:C4014887
into	I:C4014887
adipose	I:C4014887
tissue	I:C4014887
was	O
expected	O
from	O
mRNA	B:C0872262
analysis	I:C0872262
.	O

Increased	O
daily	O
energy	B:C0014272
expenditure	I:C0014272
was	O
also	O
observed	O
following	O
administration	O
of	O
compound	O
-	I:C1254351
326	I:C1254351
,	O
in	O
line	O
with	O
sustained	O
body	O
weight	I:C1262477
loss	I:C1262477
.	O

Increased	O
daily	O
energy	O
expenditure	I:C0014272
was	O
also	O
observed	O
following	O
administration	B:C1533734
of	O
compound	O
-	I:C1254351
326	I:C1254351
,	O
in	O
line	O
with	O
sustained	O
body	O
weight	I:C1262477
loss	I:C1262477
.	O

Increased	O
daily	O
energy	O
expenditure	I:C0014272
was	O
also	O
observed	O
following	O
administration	O
of	O
compound	B:C1254351
-	I:C1254351
326	I:C1254351
,	O
in	O
line	O
with	O
sustained	O
body	O
weight	I:C1262477
loss	I:C1262477
.	O

Increased	O
daily	O
energy	O
expenditure	I:C0014272
was	O
also	O
observed	O
following	O
administration	O
of	O
compound	O
-	I:C1254351
326	I:C1254351
,	O
in	O
line	O
with	O
sustained	O
body	B:C1262477
weight	I:C1262477
loss	I:C1262477
.	O

These	O
data	O
indicate	O
that	O
the	O
novel	O
Delta	B:C0057338
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
selective	O
inhibitor	O
,	O
compound	O
-	I:C1254351
326	I:C1254351
,	O
will	O
be	O
a	O
new	O
class	O
of	O
drug	O
for	O
the	O
treatment	O
of	O
obese	O
and	O
diabetic	O
patients	O
.	O

These	O
data	O
indicate	O
that	O
the	O
novel	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
selective	O
inhibitor	B:C0014432
,	O
compound	O
-	I:C1254351
326	I:C1254351
,	O
will	O
be	O
a	O
new	O
class	O
of	O
drug	O
for	O
the	O
treatment	O
of	O
obese	O
and	O
diabetic	O
patients	O
.	O

These	O
data	O
indicate	O
that	O
the	O
novel	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
selective	O
inhibitor	O
,	O
compound	B:C1254351
-	I:C1254351
326	I:C1254351
,	O
will	O
be	O
a	O
new	O
class	O
of	O
drug	O
for	O
the	O
treatment	O
of	O
obese	O
and	O
diabetic	O
patients	O
.	O

These	O
data	O
indicate	O
that	O
the	O
novel	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
selective	O
inhibitor	O
,	O
compound	O
-	I:C1254351
326	I:C1254351
,	O
will	O
be	O
a	O
new	O
class	O
of	O
drug	O
for	O
the	O
treatment	O
of	O
obese	B:C0028754
and	O
diabetic	O
patients	O
.	O

These	O
data	O
indicate	O
that	O
the	O
novel	O
Delta	O
-	I:C0057338
5	I:C0057338
desaturase	I:C0057338
selective	O
inhibitor	O
,	O
compound	O
-	I:C1254351
326	I:C1254351
,	O
will	O
be	O
a	O
new	O
class	O
of	O
drug	O
for	O
the	O
treatment	O
of	O
obese	O
and	O
diabetic	B:C0011847
patients	O
.	O

